Zoetis
ZTS
$0.82 (0.50%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 1 day ago • ZTS
The Wall Street Journal Vs. ZoetisZacks Investment Research • 6 days ago • ZTS
Here's Why Zoetis (ZTS) Gained But Lagged the Market TodayZacks Investment Research • 7 days ago • ZTS
SDZNY or ZTS: Which Is the Better Value Stock Right Now?The Motley Fool • 8 days ago • ZTS
5 Magnificent Dividend Growth Stocks Down 24% to 41% to Buy Before 2025 for a Lifetime of Passive IncomeZacks Investment Research • 11 days ago • ZTS
4 Stocks in Focus That Declared Dividend Hikes Amid Market VolatilityCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.